ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AIRO vs TMO // ALTMAN Z-SCORE & DEBT/EQUITY

AIRO Group Holdings Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AIRO 1 — TMO 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: TMO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AIRO VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AIRO TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 59.90% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -3.10% 9.30% -12.40 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield -20.68% 2.40% -23.08 TMO /fcf-yield <GO>
Operating Margin -31.60% 17.40% -49.00 TMO /operating-margins <GO>
Net Profit Margin -4.50% 15.10% -19.60 TMO /net-margins <GO>
Revenue Growth (YoY) 4.60% 3.90% +0.70 AIRO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 2.68 4.50 -1.82 TMO /balance-sheet <GO>
Piotroski F-Score Quality 5/9 8/9 -3.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.2 62.9 -25.67 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $171.7M $262.22B -$262.05B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AIRO REV TMO REV AIRO GROSS % TMO GROSS % AIRO FCF TMO FCF
FY 2025 $90.9M $44.56B 59.9% — -$35.5M $6.29B
FY 2024 $86.9M $42.88B 67.1% — $20.7M $7.27B
FY 2023 — $42.86B — — — $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AIRO // BETA —
TMO // BETA 0.94